Mary T. Szela - Aug 10, 2023 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CEO and President, Director
Signature
/s/ Mary Szela
Stock symbol
TLSI
Transactions as of
Aug 10, 2023
Transactions value $
$0
Form type
3
Date filed
8/15/2023, 04:46 PM
Previous filing
Jun 16, 2023
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TLSI Common Stock 280K Aug 10, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TLSI Employee Stock Option (right to buy) Aug 10, 2023 Common Stock 178K $1.22 Direct F1, F3
holding TLSI Employee Stock Option (right to buy) Aug 10, 2023 Common Stock 17.3K $0.41 Direct F1, F4
holding TLSI Employee Stock Option (right to buy) Aug 10, 2023 Common Stock 101K $0.41 Direct F1, F3
holding TLSI Employee Stock Option (right to buy) Aug 10, 2023 Common Stock 216K $2.43 Direct F1, F5
holding TLSI Employee Stock Option (right to buy) Aug 10, 2023 Common Stock 55.6K $2.43 Direct F1, F6
holding TLSI Employee Stock Option (right to buy) Aug 10, 2023 Common Stock 58.4K $10.30 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director and an executive officer of the Issuer. The Reporting Person was appointed as a director and an executive officer of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.).
F2 Includes 36,774 shares issued pursuant to a restricted stock unit award ("RSU"). The RSU vests in four equal annual installments commencing on October 5, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F3 The shares subject to this stock option became fully vested on January 22, 2022.
F4 The shares subject to this stock option vest in 48 equal monthly installments from the vesting commencement date of October 1, 2020, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F5 Twenty-five percent of the shares subject to the option vested on November 3, 2022, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F6 Seventy-five percent of the shares subject to this stock option vests on April 20, 2025, the third anniversary of the vesting commencement date, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F7 Twenty-five percent of the shares subject to the option vests on May 19, 2024, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.